Clinical Trial Update: QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This update reports the termination of a Phase 1/2 trial of AMG 655 in combination with AMG 479 for advanced, refractory solid tumors, with results posted on 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Sarcoma

Drugs mentioned

• AMG 479
• AMG 655 (AMG-655)

Snippet

Sponsor: NantCell, Inc. | Conditions: Colorectal Cancer, Locally Advanced | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-08-20